Elevated levels of IL-6 and IL-17 have been related to pulmonary fibrosis, and the elements of the IL-17A signaling cascade may serve as possible treatment targets for the treatment of fibroproliferative lung disorders [32]. The gene discussed is IL17A; the disease is lung disorder.